Prolight Diagnostics (“Prolight”) today announces that it has selected Integrated Technologies Limited (“ITL”) to develop the commercial instrument for its point-of-care digital immunoassay system.
This next stage of product development builds on the prototypes developed in-house at Prolight’s subsidiary Psyros Diagnostics (“Psyros”) and will ensure that the commercial instrument is state of the art and in compliance with all regulatory standards required for an IVD.
“We believe the best approach is to partner with experts in their field who can help us deliver on our vision to develop ground-breaking products for our customers. Partnering with ITL gives us an outstanding combination of technical expertise, track-record, flexibility, longer-term manufacturing capability and regulatory compliance,” said Paul Monaghan, head of engineering at Psyros.
“We are excited to join the Psyros adventure as an external partner. The team is highly capable, and it has come up with a most innovative, yet simple and elegant new IVD technology which promises to improve point of care testing worldwide. We will bring our strong capabilities and skills in the field of optics, mechanical engineering, and intimate knowledge of the manufacturing process to the table,” said Tom Ackrill, Business Development Manager at ITL.
About ITL (a G&H Company)
ITL is a specialist design and development company with significant experience in medical devices. In addition to this, ITL has the commercial scale manufacturing capability and is ISO 13485 & ISO 9001 accredited.
For over four decades, ITL has been an industry-leading outsource partner for true end-to-end design, development, and manufacturing of life-saving medical technology, diagnostic devices, and laboratory instruments. In August 2018, ITL was acquired by Gooch & Housego PLC. As part of the wider G&H Group, ITL has wide access to technology, expertise, and resources from the whole group.
About G&H
G&H is a world leader in optical designing, testing and manufacturing. As experts in the technology of light, G&H works with customers to provide optical systems, assemblies, and components for demanding applications.
Headquartered in Ilminster Somerset, UK with operations in the USA and Europe, G&H is recognized for the breadth of their acousto-optic, electro-optic, crystal-optic, fibre optic, and precision optic products. G&H is recognised as the preferred source for OEMs in the life sciences, industrial, and aerospace and defence industries, with a history of quality and excellence that dates back seventy-five years.
For further information, please contact:
Prolight Diagnostics AB (publ)
E-mail: ub@prolightdiagnostics.se
Telephone: +46 73 582 39 87
Website: www.prolightdiagnostics.se/en/
About Us
Prolight Diagnostics, together with the subsidiary Psyros Diagnostics and technology partners, develops innovative and flexible near-patient testing systems, Point-of-Care Testing (POCT), which is IT based on patented technology. POC tests are performed outside the traditional hospital laboratory with small mobile instruments in health centres, nursing homes, emergency departments, intensive care units, and other settings, enabling testing close to the patient and with rapid test results. With this technology, health care providers will be able to sort out patients in need of rapid treatment from patients that, for example, are not having a heart attack. The sales value in the POCT area amounted to USD 34.6 billion in 2021 and is growing strongly.
The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.